gms | German Medical Science

79. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

30.04. - 04.05.2008, Bonn

Malignant tumors of the nose and paranasal sinuses – diagnosis and therapeutic options

Meeting Abstract

Suche in Medline nach

  • corresponding author David Eberle - Department of Otorhinolaryngology, Head and Neck Surgery, Zentralklinikum Augsburg, Augsburg, Germany
  • author Andreas Klemens - Department of Otorhinolaryngology, Head and Neck Surgery, Zentralklinikum Augsburg, Augsburg, Germany
  • Andreas Roesler - Department of Radiology, Zentralklinikum Augsburg, Augsburg, Germany
  • Franz-Xaver Brunner - Department of Otorhinolaryngology, Head and Neck Surgery, Zentralklinikum Augsburg, Augsburg, Germany

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 79th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Bonn, 30.04.-04.05.2008. Düsseldorf, Köln: German Medical Science; 2008. Doc08hno65

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/hno2008/08hno65.shtml

Veröffentlicht: 8. Juli 2008

© 2008 Eberle et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: Despite their rareness, expanding lesions of the nose and paranasal sinuses can represent tumors of multiple entities. Due to non-specific symptoms, diagnosis often takes place at advanced stages and thus significantly affects therapy and prognosis.

Materials and methods: Retrospective analysis of data concerning diagnosis and therapy of 28 patients with malignancies of the nose and paranasal sinuses treated between 2002 and 2007 in Zentralklinikum Augsburg. This collective has been evaluated regarding the entity of the tumor, approach to therapy and five year overall survival rate.

Results: Among the entities described there were aesthesioneuroblastoma, adenocarcinoma, adenoid cystic carcinoma, squamous cell carcinoma and metastases of other primaries. The five year rate of survival is closely related to local control. Depending on the entity it varied from 25 to 60%. Individual therapy included primary surgery of the tumor and combined radiochemotherapy where appropriate.

Discussion: The choice both of surgical methods and radiotherapy is limited by the anatomical proximity to vital structures. Early diagnosis via imaging techniques and biopsies are crucial in achieving good long term follow up results. Safe surgical resection combined with radiochemotherapy (if required) and closely monitored follow-ups are essential.